Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS. - Wikidata - awgldk - TriplyDB

Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.

Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.

http://www.wikidata.org/entity/Q36218958

about

Opioids and Viral Infections: A Double-Edged Sword Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview Coupling of transient near infrared photonic with magnetic nanoparticle for potential dissipation-free biomedical application in brain Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection.Targeted drug delivery to the brain using magnetic nanoparticles.A Natural Bacterium-Produced Membrane-Bound Nanocarrier for Drug Combination Therapy.A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.Near-infrared biophotonics-based nanodrug release systems and their potential application for neuro-disorders.Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.Recent trends on hydrogel based drug delivery systems for infectious diseases Advancements in nano-enabled therapeutics for neuroHIV management.Personalized NanoMedicine: Towards new Theranostic Approach.Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues.

P2860

Q26742182-27923808-167A-4CCF-92E9-14A9B6DC530A Q26746336-5BB57C2F-FCDA-4B90-AB3E-37BD01D2B5B4 Q26770401-F340864A-0843-4B53-AD2E-8630A3006100 Q36087856-FB820B0A-2758-4408-9B66-4A0AAF3E7155 Q36245718-7FADC159-2A02-4531-B2FD-E7D78E45A9C8 Q37234713-BC7F3C6B-2EEA-4F6A-844A-88B982D76ACE Q38601774-9FB7DE98-A274-4C32-B9DC-196AF7AB5D83 Q38647298-FD3F1732-F944-4D9A-BD57-71AF1C3A5CA1 Q38654059-B63BF1C1-FF9E-4EE9-ACF6-243276351318 Q38687781-932C3817-F37A-4B7D-AD3D-77DE3441A4CF Q38748343-18A651E1-AFC6-4652-9111-20BD9D700FC9 Q38761022-88E47F59-E8F0-430B-B858-D40A39E105F6 Q38810357-A40486CE-D98A-40D5-8B6C-4C2A9A4BB71A Q40542601-EDB7B80B-F5C4-4494-B599-8DFF94CFAA99 Q42638885-64D880E5-5823-4094-99DA-7E8F6AF057BA Q47901905-AD303E6D-F2B5-4992-8046-036B22412330

P2860

Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.

http://www.wikidata.org/entity/Q36218958

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Therapeutical Neurotargeting v ...... uropathogenesis and NeuroAIDS.

@ast

Therapeutical Neurotargeting v ...... uropathogenesis and NeuroAIDS.

@en

type

label

Therapeutical Neurotargeting v ...... uropathogenesis and NeuroAIDS.

@ast

Therapeutical Neurotargeting v ...... uropathogenesis and NeuroAIDS.

@en

prefLabel

Therapeutical Neurotargeting v ...... uropathogenesis and NeuroAIDS.

@ast

Therapeutical Neurotargeting v ...... uropathogenesis and NeuroAIDS.

@en

P1433

Q36218958-FDD34F5C-FF5E-4578-AC5A-9FD27F9A4DFB

P1476

Q36218958-5B83AB36-B5D2-425C-9EEF-C5D3EFD29F4B

P2093

Q36218958-31BA2AA6-693B-4396-8CA4-DAADF357459F

Q36218958-386C80D3-D255-449E-8C84-11D54543E0B5

Q36218958-3A8640FB-B066-47C3-966C-D2E612B86052

Q36218958-76DDDCBA-8D0F-4DEC-BEFC-8F6E1CD3DDAB

Q36218958-AC0F2520-5645-4BA8-A2BA-B485A0454C8E

Q36218958-CEBCF500-660E-4FEA-83EB-6285B63F60BF

P2860

Q36218958-095E8F7C-8792-46BE-8967-9FAFFB9E5AAF

Q36218958-10542E75-DB70-43C7-AB0D-D829FD7F04E2

Q36218958-16296788-72EC-4F07-91A7-0A3633515DE5

Q36218958-1682FB74-0AEC-4A6E-91B0-04DE5C32DB82

Q36218958-1997CA40-15EF-4F01-B695-3D84B4CCD11C

Q36218958-22DBF424-9DE9-41AA-AB2D-49AFF4851B0A

Q36218958-33F2BCB3-3C61-4F7F-B7DF-8C4C76A567FD

Q36218958-35E060EA-E2D2-4E7B-9EB9-B8F303B27BBA

Q36218958-3AFA4823-5470-4728-A018-011BA2DD0FB1

Q36218958-3F40B0D1-E329-4B37-84AD-67BF9FF7F74B

P304

Q36218958-E8583A9B-0E10-494C-8D09-52E3085923CE

P31

Q36218958-2A014E90-9B54-48A5-BF17-AF62D6F0F704

P356

Q36218958-D65684A8-3B21-4487-85D7-6C3F8EDE49C6

P433

Q36218958-94B07DC6-38EF-4CC5-9889-B2B8037CDB4A

P478

Q36218958-83E9CEDB-5D37-4E39-8E1F-F6DFFC7BC18B

P50

Q36218958-1B9A10ED-5F37-4C7E-BC26-25B456B17652

Q36218958-B48538F5-05DF-4CAD-884B-B0FDCF21D496

P577

Q36218958-ED807189-7062-4B68-9A22-F059459EF26D

P5875

Q36218958-A6E5F8C9-5BB0-4584-96F6-B321A63E92FF

P698

Q36218958-54ABDC09-3C74-44D8-B5AE-44C52D701630

P921

Q36218958-3603E839-5118-455F-8DC6-C136B14E8F6B

P932

Q36218958-7EDFF459-0DAD-4ED0-A5EA-24D65E86159A

P356

P1433

Journal of Biomedical Nanotechnology

P1476

Therapeutical Neurotargeting v ...... uropathogenesis and NeuroAIDS.

@en

P2093

Adriana Y Arias

http://www.w3.org/2001/XMLSchema#string

Hong Ding

http://www.w3.org/2001/XMLSchema#string

Madhavan Nair

http://www.w3.org/2001/XMLSchema#string

Rahul D Jayant

http://www.w3.org/2001/XMLSchema#string

Sudheesh Pilakka-Kanthikeel

http://www.w3.org/2001/XMLSchema#string

Vidya Sagar

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of long-term dendritic spine alterations in Alzheimer disease models

Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation

Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study

Molecular basis of long-term plasticity underlying addiction

Molecular basis for interactions of HIV and drugs of abuse.

The potential of magneto-electric nanocarriers for drug delivery

Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.

Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder.

Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia.

P304

1722-1733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1166/JBN.2015.2108

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272176265

http://www.w3.org/2001/XMLSchema#string

P698

26502636

http://www.w3.org/2001/XMLSchema#string

P921

P932

4624254

http://www.w3.org/2001/XMLSchema#string